Epimutation profiling in Beckwith-Wiedemann syndrome: relationship with assisted reproductive technology
详细信息 查看全文
- 作者：Louise Tee (1)
Derek HK Lim (1) (2)
Renuka P Dias (1) (3)
Marie-Odile Baudement (1)
Amy A Slater (1)
Gail Kirby (1) (2)
Tom Hancocks (1)
Helen Stewart (4)
Carol Hardy (2)
Fiona Macdonald (2)
Eamonn R Maher (1) (2) (5) - 关键词：Beckwith ; Wiedemann syndrome ; Assisted reproductive technology ; Imprinting ; Genetics
- 刊名：Clinical Epigenetics
- 出版年：2013
- 出版时间：December 2013
- 年：2013
- 卷：5
- 期：1
- 全文大小：407 KB
- 参考文献：1. Reik W, Walter J: Genomic imprinting: parental influence on the genome. / Nat Rev Genet 2001, 2:21-2. CrossRef
2. Netchine I, Rossignol S, Azzi S, Le Bouc Y: Epigenetic anomalies in childhood growth disorders. / Nestle Nutr Inst Workshop Ser 2013, 71:65-3. CrossRef
3. Lim DH, Maher ER: Human imprinting syndromes. / Epigenomics 2009, 1:347-69. CrossRef
4. Reik W, Brown KW, Schneid H, Le Bouc Y, Bickmore W, Maher ER: Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. / Hum Mol Genet 1995, 4:2379-385. CrossRef
5. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le Bouc Y: Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. / Nat Genet 2005, 37:1003-007. CrossRef
6. Engel JR, Smallwood A, Harper A, Higgins MJ, Oshimura M, Reik W, Schofield PN, Maher ER: Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. / J Med Genet 2000, 37:921-26. CrossRef
7. Bliek J, Verde G, Callaway J, Maas SM, De Crescenzo A, Sparago A, Cerrato F, Russo S, Ferraiuolo S, Rinaldi MM, Fischetto R, Lalatta F, Giordano L, Ferrari P, Cubellis MV, Larizza L, Temple IK, Mannens MM, Mackay DJ, Riccio A: Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. / Eur J Hum Genet 2009, 17:611-19. CrossRef
8. Rossignol S, Steunou V, Chalas C, Kerjean A, Rigolet M, Viegas-Pequignot E, Jouannet P, Le Bouc Y, Gicquel C: The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region. / J Med Genet 2006, 43:902-07. CrossRef
9. Halliday J, Oke K, Breheny S, Algar E, Amor DJ: Beckwith-Wiedemann syndrome and IVF: a case–control study. / Am J Hum Genet 2004, 75:526-28. CrossRef
10. Lim D, Bowdin SC, Tee L, Kirby GA, Blair E, Fryer A, Lam W, Oley C, Cole T, Brueton LA, Reik W, Macdonald F, Maher ER: Clinical and molecular genetic features of Beckwith-Wiedemann syndrome associated with assisted reproductive technologies. / Hum Reprod 2009, 24:741-47. CrossRef
11. Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, Macdonald F, Sampson JR, Barratt CL, Reik W, Hawkins MM: Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). / J Med Genet 2003, 40:62-4. CrossRef
12. Cooper WN, Curley R, Macdonald F, Maher ER: Mitotic recombination and uniparental disomy in Beckwith-Wiedemann syndrome. / Genomics 2007, 89:613-17. CrossRef
13. McRonald FE, Morris MR, Gentle D, Winchester L, Baban D, Ragoussis J, Clarke NW, Brown MD, Kishida T, Yao M, Latif F, Maher ER: CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. / Mol Cancer 2009, 8:31. CrossRef
14. Horike S, Mitsuya K, Meguro M, Kotobuki N, Kashiwagi A, Notsu T, Schulz TC, Shirayoshi Y, Oshimura M: Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. / Hum Mol Genet 2000, 9:2075-083. CrossRef
15. Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. / Nature 2000, 405:482-85. CrossRef
16. Mackay DJ, Callaway JL, Marks SM, White HE, Acerini CL, Boonen SE, Dayanikli P, Firth HV, Goodship JA, Haemers AP, Hahnemann JM, Kordonouri O, Masoud AF, Oestergaard E, Storr J, Ellard S, Hattersley AT, Robinson DO, Temple IK: Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. / Nat Genet 2008, 40:949-51. CrossRef
17. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S, Rouleau GA, Slim R: Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. / Nat Genet 2006, 38:300-02. CrossRef
18. Meyer E, Lim D, Pasha S, Tee LJ, Rahman F, Yates JR, Woods CG, Reik W, Maher ER: Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann syndrome). / PLoS Genet 2009, 5:e1000423. CrossRef
19. Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, Le Bouc Y: In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. / Am J Hum Genet 2003, 72:1338-341. CrossRef
20. Manipalviratn SA, DeCherney A, Segars J: Imprinting disorders and assisted reproductive technology. / Fertil Steril 2009, 91:305-15. CrossRef
21. Owen CM, Segars JH Jr: Imprinting disorders and assisted reproductive technology. / Semin Reprod Med 2009, 27:417-28. CrossRef
22. Sutcliffe AG, Peters CJ, Bowdin S, Temple K, Reardon W, Wilson L, Clayton-Smith J, Brueton LA, Bannister W, Maher ER: Assisted reproductive therapies and imprinting disorders–a preliminary British survey. / Hum Reprod 2006, 21:1009-011. CrossRef
23. Dias RP, Bogdarina I, Cazier JB, Buchanan C, Donaldson MC, Johnston LB, Hokken-Koelega AC, Clark AJ: Multiple segmental uniparental disomy associated with abnormal DNA methylation of imprinted Loci in silver-russell syndrome. / J Clin Endocrinol Metab 2012, 97:E2188-E2193. CrossRef
24. Azzi S, Rossignol S, Steunou V, Sas T, Thibaud N, Danton F, Le Jule M, Heinrichs C, Cabrol S, Gicquel C, Le Bouc Y, Netchine I: Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. / Hum Mol Genet 2009, 18:4724-733. CrossRef
25. Court F, Martin-Trujillo A, Romanelli V, Garin I, Iglesias-Platas I, Salafsky I, Guitart M, Perez de Nanclares G, Lapunzina P, Monk D: Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes. / Hum Mutat 2013, 34:595-02.
26. Poole RL, Docherty LE, Al Sayegh A, Caliebe A, Turner C, Baple E, Wakeling E, Harrison L, Lehmann A, Temple IK, Mackay DJ, International Clinical Imprinting Consortium: Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders. / Am J Med Genet A 2013, 161:2174-182. CrossRef
27. Hiura H, Okae H, Miyauchi N, Sato F, Sato A, Van De Pette M, John RM, Kagami M, Nakai K, Soejima H, Ogata T, Arima T: Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. / Hum Reprod 2012, 27:2541-548. CrossRef
28. Docherty LE, Kabwama S, Lehmann A, Hawke E, Harrison L, Flanagan SE, Ellard S, Hattersley AT, Shield JP, Ennis S, Mackay DJ, Temple IK: Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. / Diabetologia 2013, 56:758-62. CrossRef
29. Elliott M, Bayly R, Cole T, Temple IK, Maher ER: Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. / Clin Genet 1994, 46:168-74. CrossRef
30. Abu-Amero S, Monk D, Frost J, Preece M, Stanier P, Moore GE: The genetic aetiology of Silver-Russell syndrome. / J Med Genet 2008, 45:193-99. CrossRef
31. Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA: Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene mest. / Nat Genet 1998, 20:163-69. CrossRef
32. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D, Hassan AB: Insulin-like growth factor ligands, receptors, and binding proteins in cancer. / J Pathol 2005, 205:145-53. CrossRef
33. Xu Y, Goodyer CG, Deal C, Polychronakos C: Functional polymorphism in the parental imprinting of the human IGF2R gene. / Biochem Biophys Res Commun 1993, 197:747-54. CrossRef
34. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD: Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. / Nat Genet 2001, 27:153-54. CrossRef
35. Turner CL, Mackay DM, Callaway JL, Docherty LE, Poole RL, Bullman H, Lever M, Castle BM, Kivuva EC, Turnpenny PD, Mehta SG, Mansour S, Wakeling EL, Mathew V, Madden J, Davies JH, Temple IK: Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. / Eur J Hum Genet 2010, 18:648-55. CrossRef
36. Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B: Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. / Am J Hum Genet 2003, 72:571-77. CrossRef
37. Bens S, Haake A, Richter J, Leohold J, Kolarova J, Vater I, Riepe FG, Buiting K, Eggermann T, Gillessen-Kaesbach G, Platzer K, Prawitt D, Caliebe A, Siebert R: Frequency and characterization of DNA methylation defects in children born SGA. / Eur J Hum Genet 2013, 21:838-43. CrossRef
38. Amor DJ, Halliday J: A review of known imprinting syndromes and their association with assisted reproduction technologies. / Hum Reprod 2008, 23:2826-834. CrossRef
39. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, Aknin C, Severac D, Chotard L, Kahli M, Le Digarcher A, Pavlidis P, Journot L: Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. / Dev Cell 2006, 11:711-22. CrossRef
40. Zhao Z, Tavoosidana G, Sj?linder M, G?nd?r A, Mariano P, Wang S, Kanduri C, Lezcano M, Sandhu KS, Singh U, Pant V, Tiwari V, Kurukuti S, Ohlsson R: Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. / Nat Genet 2006, 38:1341-347. CrossRef - 作者单位：Louise Tee (1)
Derek HK Lim (1) (2)
Renuka P Dias (1) (3)
Marie-Odile Baudement (1)
Amy A Slater (1)
Gail Kirby (1) (2)
Tom Hancocks (1)
Helen Stewart (4)
Carol Hardy (2)
Fiona Macdonald (2)
Eamonn R Maher (1) (2) (5)
1. Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
2. West Midlands Regional Genetics Service, Birmingham Women’s Hospital, Edgbaston, Birmingham, B15 2TG, UK
3. Department of Endocrinology, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK
4. Department of Clinical Genetics, Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK
5. Department of Medical Genetics, University of Cambridge, Cambridge, CB2 2QQ, UK - ISSN：1868-7083
文摘
Background Beckwith-Wiedemann syndrome (BWS) is a congenital overgrowth disorder associated with abnormalities in 11p15.5 imprinted genes. The most common cause is loss of methylation (epimutation) at the imprinting control centre 2 (IC2/KvDMR1). Most IC2 epimutations occur sporadically but an association with conception after assisted reproductive technologies (ART) has been reported. A subgroup of IC2 epimutation cases also harbour epimutations at other imprinting centres (ICs) outside of 11p15.5. We have investigated the relationship between these multiple epimutation cases (ME+), history of ART and clinical phenotype in a cohort of 187 BWS IC2 epimutation patients. Results Methylation analysis at PLAGL1, MEST and IGF2R ICs demonstrated an over-representation of patients with abnormally low methylation (8.5%, 12% and 6% respectively). At IGF2R some patients (2%) had gain of methylation but this was also detected in controls. Though there were no significant correlations between the methylation index (MIs) at the three ICs tested, a subset of patients appeared to be susceptible to multiple epimutations (ME+) and 21.2% of ME-?patients had been conceived by ART compared to 4.5% (P--.0033) without additional epimutations. Methylation array profiling (Illumina Goldengate?) of patients and controls (excluding 11p15.5 loci) demonstrated significant differences between patients and controls. No significant associations were found between aspects of the BWS phenotype and individual epimutations but we describe a case presenting with a post-ART BWS-like phenotype in which molecular analysis demonstrated loss of paternal allele methylation at the 11p15.5 IC1 locus (IC1 regulates imprinting of IGF2 and H19). Loss of paternal allele methylation at the IC1 is the molecular finding associated with Silver-Russell syndrome whereas BWS is associated with gain of maternal allele methylation at IC1. Further analysis demonstrated epimutations at PLAGL1 and MEST consistent with the hypothesis that the presence of multiple epimutations may be of clinical relevance. Conclusions These findings suggest that the ME-?subgroup of BWS patients are preferentially, but not exclusively, associated with a history of ART and that, though at present, there are no clear epigenotype-phenotype correlations for ME-?BWS patients, non-11p15.5 IC epimutations can influence clinical phenotype.